Leprosy - Number of cases registered for treatment in United Kingdom of Great Britain and Northern Ireland
United Kingdom of Great Britain and Northern Ireland: Leprosy - Number of cases registered for treatment was 12 in 2024. ◆ Volatile
Leprosy - Number of cases registered for treatment in United Kingdom of Great Britain and Northern Ireland, 2016–2024
Source: World Health Organization, Global Health Observatory.
Analysis
United Kingdom of Great Britain and Northern Ireland recorded 12 for leprosy - number of cases registered for treatment in 2024. That is the highest value across all 8 years on record.
The figure is up 140.0% on the previous year and up 140.0% over ten years.
Over the whole period, leprosy - number of cases registered for treatment in United Kingdom of Great Britain and Northern Ireland peaked at 12 in 2024 and was at its lowest, 0, in 2017.
United Kingdom of Great Britain and Northern Ireland ranks 80th of 169 countries on this measure, in the middle of the range.
Leprosy - Number of cases registered for treatment in United Kingdom of Great Britain and Northern Ireland, year by year
| Year | Value | Change |
|---|---|---|
| 2016 | 5 | — |
| 2017 | 0 | -100.0% |
| 2019 | 4 | — |
| 2020 | 6 | +50.0% |
| 2021 | 5 | -16.7% |
| 2022 | 10 | +100.0% |
| 2023 | 5 | -50.0% |
| 2024 | 12 | +140.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3 | 0 | 5 | 3 |
| 2020s | 7.6 | 5 | 12 | 5 |
Countries ranked near United Kingdom of Great Britain and Northern Ireland
More health data for United Kingdom of Great Britain and Northern Ireland
- Un projection of annual infant deaths, annual growth rate -1.71 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0265 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,134 deaths per 1,000 people (2090)
- Number of infants who die before age 1 461 deaths (2100)
- Population ages 15-19, male, annual growth rate 2.35 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0311 units per person (2025)
- Population ages 20-24, female, annual growth rate 1.52 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0283 units per person (2025)
All data for United Kingdom of Great Britain and Northern Ireland →
Frequently asked questions
- What is leprosy - number of cases registered for treatment in United Kingdom of Great Britain and Northern Ireland?
- Leprosy - number of cases registered for treatment in United Kingdom of Great Britain and Northern Ireland was 12 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest leprosy - number of cases registered for treatment recorded in United Kingdom of Great Britain and Northern Ireland?
- The highest recorded value was 12 in 2024.
- What is the lowest leprosy - number of cases registered for treatment recorded in United Kingdom of Great Britain and Northern Ireland?
- The lowest recorded value was 0 in 2017.
- How does United Kingdom of Great Britain and Northern Ireland rank for leprosy - number of cases registered for treatment?
- United Kingdom of Great Britain and Northern Ireland ranks 80th out of 169 countries with data for 2024.
- Is leprosy - number of cases registered for treatment rising or falling in United Kingdom of Great Britain and Northern Ireland?
- Over the last ten years it is up 140.0%. The long-run trend across the full record is volatile.
- Where does this United Kingdom of Great Britain and Northern Ireland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Leprosy - Number of cases registered for treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).